Muscle can be rebuilt. That part is genuinely good news, and it is worth saying before the caveats. Muscle tissue responds to training and protein throughout life, including in people who have lost a substantial amount of it.
The caveats are about what usually happens rather than what is possible.
What the trial data shows about weight
The STEP 1 trial extension followed participants for a year after semaglutide was withdrawn. In that group, mean weight loss over the 68 weeks on treatment was 17.3%. A year after stopping, they had regained about two thirds of it — 11.6 percentage points — leaving a net loss of 5.6% from where they began.
So weight comes back, and it comes back substantially. This is the finding that gets quoted, usually to make a point about needing to stay on the medication. It is also the finding that matters most for this question, because of what regained weight is typically made of.
The asymmetry
Weight lost in a deficit is a mixture of fat and lean tissue. Weight regained without resistance training is disproportionately fat.
This is not a quirk of these medications. It is the ordinary pattern in weight-cycling research, and it is why repeated cycles of loss and regain tend to leave people with a higher body fat percentage than they started with at a similar body weight. The scale returns to where it was. The composition underneath it does not.
Muscle regain is not automatic, in other words. Fat regain largely is.
What changes the outcome
The thing that separates the two cases is whether you are training.
If you stop the medication and continue resistance training with adequate protein, regained weight has a reason to include muscle, and the picture is far better. If you stop and let everything else go with it — which is common, because the structure often disappears when the drug does — then the weight returns and very little of it is lean tissue.
This is the strongest practical argument for building the training habit while you are still on the medication rather than after. Not because training does much for the rate of weight loss, but because it is what determines the shape of whatever happens next.
An honest limitation
The specific question — how much muscle GLP-1 users regain after stopping, and under what conditions — has less direct evidence behind it than we would like. The weight-regain data is solid. The composition-of-regain data in this exact population is much thinner, and most of what is said about it is extrapolated from older weight-cycling literature rather than measured in people coming off semaglutide or tirzepatide.
We would rather say that than write around it. The section above is reasonable inference from adjacent evidence, not a trial result, and you should weigh it accordingly.
What is worth doing
If you are still on the medication, the useful move is to establish resistance training now, while appetite suppression makes the weight side easy. Two or three sessions a week is enough, and the habit is the asset — not the weight on the bar.
If you have already stopped, the position is workable rather than lost. Muscle responds to training at any point. Protein intake matters more, not less, once appetite returns and total intake climbs. And if weight is returning quickly, that is worth raising with your prescriber — stopping is not always permanent, and that decision is a clinical one.
The muscle check works the same way whether or not you are currently taking anything. If you want to know where you stand now, it will tell you, and it will name the one thing worth changing first.